The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer

The treatment of metastatic non-small cell lung cancer (NSCLC) has undergone a paradigm shift over the last decade. Better molecular characterization of the disease has led to the rapid improvement of personalized medicine and the prompt delivery of targeted therapies to patients with NSCLC. The dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gristina, Valerio, La Mantia, Maria, Iacono, Federica, Galvano, Antonio, Russo, Antonio, Bazan, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766858/
https://www.ncbi.nlm.nih.gov/pubmed/33352844
http://dx.doi.org/10.3390/ph13120474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766858/
https://www.ncbi.nlm.nih.gov/pubmed/33352844
http://dx.doi.org/10.3390/ph13120474

Ejemplares similares